Four details:
1. FemSelect, an Israeli medtech company, designed EnPlace for vaginal colpopexy by sacrospinous ligament fixation.
2. CMS created the CPT code (C9778: Colpopexy, minimally invasive, extraperitoneal) following a review of the company’s New Technology Ambulatory Payment Classification, which outlines services or procedures “new and significant enough to warrant having a unique code under the Healthcare Common Procedure Coding System,” according to the agency.
3. EnPlace is positioned for appropriate payment as a level 5 GYN procedure and designated as device intensive, which increases access to the procedure in the ASC setting, CMS said in a Nov. 10 news release.
4. Pelvic organ prolapse is a condition in which one or more female pelvic floor organs descend, with symptoms including discomfort, embarrassment and urinary and sexual dysfunction. Half of women older than 50 suffer from a pelvic floor condition, according to FemSelect.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.